460 related articles for article (PubMed ID: 16167831)
1. Anthocyanidins modulate the activity of human DNA topoisomerases I and II and affect cellular DNA integrity.
Habermeyer M; Fritz J; Barthelmes HU; Christensen MO; Larsen MK; Boege F; Marko D
Chem Res Toxicol; 2005 Sep; 18(9):1395-404. PubMed ID: 16167831
[TBL] [Abstract][Full Text] [Related]
2. Delphinidin modulates the DNA-damaging properties of topoisomerase II poisons.
Esselen M; Fritz J; Hutter M; Marko D
Chem Res Toxicol; 2009 Mar; 22(3):554-64. PubMed ID: 19182879
[TBL] [Abstract][Full Text] [Related]
3. Differential cytotoxic pathways of topoisomerase I and II anticancer agents after overexpression of the E2F-1/DP-1 transcription factor complex.
Hofland K; Petersen BO; Falck J; Helin K; Jensen PB; Sehested M
Clin Cancer Res; 2000 Apr; 6(4):1488-97. PubMed ID: 10778981
[TBL] [Abstract][Full Text] [Related]
4. Alternariol acts as a topoisomerase poison, preferentially affecting the IIalpha isoform.
Fehr M; Pahlke G; Fritz J; Christensen MO; Boege F; Altemöller M; Podlech J; Marko D
Mol Nutr Food Res; 2009 Apr; 53(4):441-51. PubMed ID: 18727009
[TBL] [Abstract][Full Text] [Related]
5. Distinct patterns of cell cycle disturbance elicited by compounds interfering with DNA topoisomerase I and II activity.
Poot M; Hiller KH; Heimpel S; Hoehn H
Exp Cell Res; 1995 May; 218(1):326-30. PubMed ID: 7537696
[TBL] [Abstract][Full Text] [Related]
6. Covalent attachment of ethidium to DNA results in enhanced topoisomerase II-mediated DNA cleavage.
Marx G; Zhou H; Graves DE; Osheroff N
Biochemistry; 1997 Dec; 36(50):15884-91. PubMed ID: 9398321
[TBL] [Abstract][Full Text] [Related]
7. [Poisons of DNA topoisomerases I and II].
Charcosset JY; Soues S; Laval F
Bull Cancer; 1993 Nov; 80(11):923-54. PubMed ID: 8081034
[TBL] [Abstract][Full Text] [Related]
8. Anthocyanin-rich extracts suppress the DNA-damaging effects of topoisomerase poisons in human colon cancer cells.
Esselen M; Fritz J; Hutter M; Teller N; Baechler S; Boettler U; Marczylo TH; Gescher AJ; Marko D
Mol Nutr Food Res; 2011 May; 55 Suppl 1():S143-53. PubMed ID: 21280204
[TBL] [Abstract][Full Text] [Related]
9. F 11782, a novel catalytic inhibitor of topoisomerases I and II, induces atypical, yet cytotoxic DNA double-strand breaks in CHO-K1 cells.
Barret JM; Etiévant C; Baudouin C; Skov K; Charvéron M; Hill BT
Anticancer Res; 2002; 22(1A):187-92. PubMed ID: 12017285
[TBL] [Abstract][Full Text] [Related]
10. A three-dimensional quantitative structure-activity relationship study of the inhibition of the ATPase activity and the strand passing catalytic activity of topoisomerase IIalpha by substituted purine analogs.
Jensen LH; Liang H; Shoemaker R; Grauslund M; Sehested M; Hasinoff BB
Mol Pharmacol; 2006 Nov; 70(5):1503-13. PubMed ID: 16880287
[TBL] [Abstract][Full Text] [Related]
11. Lycobetaine acts as a selective topoisomerase II beta poison and inhibits the growth of human tumour cells.
Barthelmes HU; Niederberger E; Roth T; Schulte K; Tang WC; Boege F; Fiebig HH; Eisenbrand G; Marko D
Br J Cancer; 2001 Nov; 85(10):1585-91. PubMed ID: 11720449
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of DNA topoisomerases by sanguiin H-6, a cytotoxic dimeric ellagitannin from Sanguisorba officinalis.
Bastow KF; Bori ID; Fukushima Y; Kashiwada Y; Tanaka T; Nonaka G; Nishioka I; Lee KH
Planta Med; 1993 Jun; 59(3):240-5. PubMed ID: 8391144
[TBL] [Abstract][Full Text] [Related]
13. Cationic porphyrins and analogues as new DNA topoisomerase I and II inhibitors.
Shuai L; Wang S; Zhang L; Fu B; Zhou X
Chem Biodivers; 2009 Jun; 6(6):827-37. PubMed ID: 19551725
[TBL] [Abstract][Full Text] [Related]
14. Synergistic interactions between tumor necrosis factor and inhibitors of DNA topoisomerase I and II.
Baloch Z; Cohen S; Coffman FD
J Immunol; 1990 Nov; 145(9):2908-13. PubMed ID: 2170526
[TBL] [Abstract][Full Text] [Related]
15. Use of catalytic topoisomerase II inhibitors to probe mechanisms of chemical-induced clastogenicity in Chinese hamster V79 cells.
Snyder RD
Environ Mol Mutagen; 2000; 35(1):13-21. PubMed ID: 10692223
[TBL] [Abstract][Full Text] [Related]
16. The substitution pattern of anthocyanidins affects different cellular signaling cascades regulating cell proliferation.
Marko D; Puppel N; Tjaden Z; Jakobs S; Pahlke G
Mol Nutr Food Res; 2004 Sep; 48(4):318-25. PubMed ID: 15497183
[TBL] [Abstract][Full Text] [Related]
17. Fluorometric assays for DNA topoisomerases and topoisomerase-targeted drugs: quantitation of catalytic activity and DNA cleavage.
Andrea JE; Adachi K; Morgan AR
Mol Pharmacol; 1991 Oct; 40(4):495-501. PubMed ID: 1656189
[TBL] [Abstract][Full Text] [Related]
18. Effects of morpholinyl doxorubicins, doxorubicin, and actinomycin D on mammalian DNA topoisomerases I and II.
Wassermann K; Markovits J; Jaxel C; Capranico G; Kohn KW; Pommier Y
Mol Pharmacol; 1990 Jul; 38(1):38-45. PubMed ID: 2164630
[TBL] [Abstract][Full Text] [Related]
19. Human DNA topoisomerase inhibitors from Potentilla argentea and their cytotoxic effect against MCF-7.
Tomczyk M; Drozdowska D; Bielawska A; Bielawski K; Gudej J
Pharmazie; 2008 May; 63(5):389-93. PubMed ID: 18557426
[TBL] [Abstract][Full Text] [Related]
20. Binding of DNA topoisomerases I and II to replication origins.
Falaschi A
Methods Mol Biol; 2009; 582():131-43. PubMed ID: 19763947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
